Trexquant Investment LP Siga Technologies Inc Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.32 - $10.46 $1.53 Million - $2.53 Million	242,313 New	242,313 $1.84 Million
Q4 2022 Feb 13, 2023	SELL	$7.29 - $10.14 $965,283 - $1.34 Million	-132,412 Reduced 69.52%	58,059 $427,000
Q3 2022 Nov 14, 2022	BUY	$10.02 - $26.15 $1.91 Million - $4.98 Million	190,471 New	190,471 $1.96 Million
Q2 2022 Aug 11, 2022	SELL	$6.5 - $13.68 $140,517 - $295,734	-21,618 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.96 - $7.61 $128,843 - $164,512	21,618 New	21,618 $153,000
Q1 2019 May 13, 2019	SELL	$5.66 - $7.89 $154,212 - $214,970	-27,246 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$4.77 - $7.9 $129,963 - $215,243	27,246 New	27,246 $215,000

185

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $438M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.